MFC Co., Ltd. Logo

MFC Co., Ltd.

A GMP-certified CDMO/CMO developing and manufacturing APIs for the global pharma sector.

432980 | KO

Overview

Corporate Details

ISIN(s):
KR7432980001
LEI:
Country:
South Korea
Address:
경기도 화성시 마도면 청원산단7길 35(청원리 1453), 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 2008, MFC Co., Ltd. is a pharmaceutical company specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and key intermediates. The company offers Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) services tailored to the global pharmaceutical sector. As a GMP-certified manufacturer, MFC focuses on producing high-quality raw medicines and new APIs, aiming to become a global leader in pharmaceutical development and technology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-03 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 82.4 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.0 MB
2025-06-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 780.1 KB
2025-04-04 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-03-31 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.0 KB
2025-03-28 00:00
Board/Management Information
대표이사변경
Korean 12.3 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 28.6 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 19.1 KB
2025-03-20 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 423.5 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 85.2 KB
2025-03-07 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 16.4 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 5.0 KB
2025-02-28 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 66.5 KB

Automate Your Workflow. Get a real-time feed of all MFC Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MFC Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MFC Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Shedir Pharma Group Logo
Develops and sells pharmaceutical, nutraceutical, and dermo-cosmetic products in Italy & Spain.
Italy
SHE
SHIELD THERAPEUTICS PLC Logo
Commercializing a novel oral therapy for adults with iron deficiency.
United Kingdom
STX
SHINPOONG PHARMACEUTICAL CO.,LTD Logo
R&D-driven pharma firm making APIs, finished drugs, and medical products for global markets.
South Korea
019170
Shionogi & Co.,Ltd. Logo
A research-driven pharmaceutical firm creating drugs, diagnostics, and devices for global health.
Japan
4507
Shuttle Pharmaceuticals Holdings, Inc. Logo
Develops drugs to enhance radiation therapy for cancer and offers predictive diagnostics.
United States of America
SHPH
Siegfried Holding AG Logo
Global CDMO providing development and manufacturing of APIs and finished drugs for the pharma industry.
Switzerland
SFZN
SIGA TECHNOLOGIES INC Logo
Develops antiviral drugs for global health security against biothreats and infectious diseases.
United States of America
SIGA
Silexion Therapeutics Corp Logo
Developing a local drug delivery platform to treat KRAS-driven cancers and solid tumors.
United States of America
SLXN
Develops oncolytic viruses and immunotherapeutics to destroy difficult-to-treat cancer cells.
South Korea
215600
Silo Pharma, Inc. Logo
Develops novel psychedelic & traditional therapies for pain and central nervous system disorders.
United States of America
SILO

Talk to a Data Expert

Have a question? We'll get back to you promptly.